Author

Travis A. Pemberton

Bristol-Myers Squibb (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alan F. CoriniD· 1 shared Ali E. YesilkanaliD· 1 shared Amit Anand· 1 shared Ashish K. Singh· 1 shared Aya M. KellyiD· 1 shared Benjamin Causton· 1 shared Denise A. CobbiD· 1 shared Emily FuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alan F. CorinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CK2 directly controls CARD9 protein homeostasis

Aya M. Kelly, Leidy C. Merselis, Benjamin Causton, Olivia K. Calder, Hoson Chao, Margaret M. Prack, Laurel B. Stine, Yuka Amako, Tao Wang, Ali E. Yesilkanal, Kendall J. Condon, Meekyum O. Pierce, Scott H. Watterson, Jason M. Guernon, Amit Anand, , Stephen C. Wilson

This study identifies CK2 as a regulator of CARD9 protein stability, showing CK2 inhibition leads to CARD9 depletion and demonstrating therapeutic potential in vivo.

ACS Chemical Biology · May 16, 2026Peer-reviewedImmunology